-transparent.png){kind=logo}
The plasma concentration of proscillaridin was measured by a modified 86Rb method during treatment with multiple doses of a commercial preparation of proscillaridin. Despite high doses, very low plasma levels were found, and there were only minute amounts of glycoside activity in urine and faeces. Administration of an enteric-coated proscillaridin preparation gave higher plasma levels, which raises the possibility of inactivation of the glycoside by acid gastric juice. The results suggest that proscillaridin has low biological availability when given orally, and that it is extensively metabolised in the body.
Related Publications
K E Andersson, and
A Bertler, and
A Redfors
January 1974,
Naunyn-Schmiedeberg's archives of pharmacology,
K E Andersson, and
A Bertler, and
A Redfors
June 1976,
European journal of clinical pharmacology,
K E Andersson, and
A Bertler, and
A Redfors
January 1979,
Arzneimittel-Forschung,
K E Andersson, and
A Bertler, and
A Redfors
February 1965,
Wiener medizinische Wochenschrift (1946),
K E Andersson, and
A Bertler, and
A Redfors
April 1975,
European journal of clinical pharmacology,
K E Andersson, and
A Bertler, and
A Redfors
May 1975,
Experientia,
K E Andersson, and
A Bertler, and
A Redfors
September 1967,
Die Medizinische Welt,
K E Andersson, and
A Bertler, and
A Redfors
February 1977,
Acta pharmacologica et toxicologica,
K E Andersson, and
A Bertler, and
A Redfors
January 1983,
Arzneimittel-Forschung,
K E Andersson, and
A Bertler, and
A Redfors
January 1982,
Arzneimittel-Forschung,
